Genetic testing study for heart defects in pregnancy
Part of Genetic & congenital, Heart & circulation clinical trials.
This study tests a new way to find genetic causes of congenital heart disease (a heart problem found before birth) using samples from amniocentesis or chorionic villus sampling. It may help parents get a clearer diagnosis and plan for their baby's care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and the baby has been found to have a heart defect before birth.
- You plan to have amniocentesis or chorionic villus sampling (tests that take fluid or tissue from around the baby).
- You want to learn more about the genetic reason for the heart problem.
- You are at least 18 years old.
- Your pregnancy is less than 38 weeks along.
- The heart defect is not already explained by a known genetic diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genetic material in the fluid around the baby (amniotic fluid) and in the placenta to better understand complex heart defects in unborn babies. The goal is to find new clues that could help doctors care for these babies before and after birth.
This study looks at how genes may contribute to congenital heart disease. It may help researchers better understand causes and risk in families like yours.
This study looks for chromosome changes in children born with heart defects. It may help doctors understand why some children have these conditions.
This study uses advanced genetic testing (whole genome sequencing) on tissue samples from fetuses with structural abnormalities detected on ultrasound. The goal is to identify genetic causes of birth defects to help with diagnosis and understanding of your baby's condition.
This trial uses genetic testing to better understand the cause of a newborn’s birth defect and to help doctors choose more personalized treatment. It may help families get clearer answers and more targeted care.
This study uses whole-genome sequencing (a DNA test that looks across the genome) for newborns in the intensive care unit when doctors suspect a genetic condition. It aims to help identify possible genetic causes of illness and improve understanding for families and clinicians.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.